Upjohn Company, Kalamazoo, MI) and rifampin (Calbiochem, La Jolla, CA).
Leukocytes
Human polymorphonuclear neutrophils (PMNs) were isolated as described previously11). Thymocytes were obtained from 10-to 15-day old CF-1 mice sacrificed by cervical dislocation after ether anesthesia. The tissue was immersed in ice-cold HHG, pressed through a wire screen, then 2 layers of silk. The thymocytes were washed twice and resuspended in HHG. Mouse leukemia L1210 cells were kindly provided by T. WALLACE, Cancer Research, The Upjohn Company. Frozen L1210 cells were cultured in RPMI 1634 containing 5 % fetal calf serum (Hyclone Laboratories, Logan, UT) at 37°C for 24 hours. They were placed into fresh media, 5 x 104/ml, and incubated for an additional 24 hours. The L1210 cells were washed twice and resuspended in HHG to a concentration of 5 x 106/ml. Antibiotic-to-leukocyte Binding System An outline of the system is shown in Fig. I and has been described in detail elsewhere27r. After incubation of antibiotic with leukocytes, rather than using centrifugation to wash off extracellular antibiotics, leukocytes were centrifuged through silicone oil (#550, Dow Corning Corp., Midland, MI) leaving antibiotics behind in the aqueous phase28). Contact between S. aureus 502a and the phagocyte-antibiotic complex was assured by centrifugation at 4°C in 96-well tissue culture trays, phagocytosis was induced by incubation at 37°C, leukocytes were lyzed by freezing and thawing the trays, and assessment of viable bacteria was accomplished by collecting [3H]thymidine labeled bacteria using a cell harvester. An additional modification from the original procedure involved preincubating the frozen bacteria for 1 hour at 37°C before addition of [3H]thymidine; this resulted in increased KCPM. Each value reported represents the mean ±1 standard deviation (using N-1) of quadruplicate samples of each antibiotic concentration.
Quantitation of Antibiotic Bound to Leukocytes
In order to estimate how much antibiotic actually bound to leukocytes, antibiotics were added directly to PMNs and S. aureus at 0°C, which effectively blocked binding5,27). These trays were then processed in the same manner as those used above in the binding system. The resulting curves of inhibition, which represented the sum contribution of the PMNs and antibiotic, were then superimposed over inhibition curves obtained from the binding system and, in this way, the amount of antibiotic carried by the leukocyte could be estimated.
Results

Comparison of Antibiotic Binding to PMNs, L1210 Cells and Thymocytes
Preliminary experiments with each cell type were performed to estimate the antibiotic concentra- PMNs although binding was substantially less to thymocytes. In order to make direct comparisons, the three cell types were then examined simultaneously in the same experiments for antibiotic binding (only those antibiotics that bound to PMNs were tested with the other cell types). Clindamycin bound to PMNs and L1210 cells in a concentration-dependent fashion (Fig. 2) ; greater inhibition of [3H]thymidine uptake accompanied increased clindamycin concentrations. However, no binding to thymocytes was observed at concentrations up to 20 yg clindamycin per ml. Tetracycline ( Fig. 3) resembled clindamycin in that a concentration-dependent effect was seen with PMNs and L1210 cells, although tetracycline bound somewhat less to L1210 cells. Again, no binding to thymocytes was observed at the highest tetracycline concentration tested (20 yg/ml). Similar results were obtained with novobiocin ( Fig. 4 ) except that inhibitory activity was seen at much lower incubation concentrations compared with clindamycin and tetracycline. In addition, binding to thymocytes was observed. Likewise, fusidic acid ( 
Quantitation of Antibiotic Bound to Leukocytes
The differences in the results between antibiotics could suggest that some antibiotics bound to were added directly to PMNs and bacteria versus effects by the antibiotics after being bound and carried by PMNs. The inhibitory curves generated by direct antibiotic addition were then superimposed over those obtained by antibiotic/leukocyte incubation. In this way, the amount carried by the leukocyte could be estimated.
Representative experiments with clindamycin ( Fig. 8 ), fusidic acid (Fig. 9 ), and rifampin ( Fig. 10) were selected for presentation because of their range of potency in inhibiting [3H]thymidine uptake;
clindamycin (weak), fusidic acid (moderate), and rifampin (strong). When clindamycin was incubated at 10 ug/ml, this was equivalent to the direct addition of 50 n,-/ml, Leukocyte incubation with fusidic acid at 1.25 ,rig/ml was equivalent to adding 20 ng/ml; incubation with rifampin at 0.3 /ug/ ml was equivalent to adding 1 ng/ml. Thus, the differences between the antibiotics was a reflection of their intrinsic inhibitory potencies on [3H]thymidine uptake in addition to their binding capabilities. The theoretical amount of antibiotic bound was arbitrarily calculated at the concentration at which [3H]thymidine uptake was inhibited by 50% (ICS,). This was, for clindamycin, 40 fg/PMN (from Fig. 8, IC50 -100 fg/ml divided by 2.5 x 108 PMNs/ml); fusidic acid=8 fg/PMN (Fig. 9 , ICSO= 20 n,-/ml); rifampin=0.4 fg/PMN (Fig. 10, IC50=1 ng/ml). Replicate experiments yielded results 
Discussion
The results of this study lead to the following conclusions. The modified antibiotic-to-leukocyte binding system can be used with a variety of cells including either phagocytic or non-phagocytic leukocytes. Second, antibiotics that bound to phagocytic leukocytes (PMNs) usually bound equally well to mouse leukemia cells, but much less to mouse thymocytes. These results, coupled together with previous work using mononuclear leukocytes and erythrocytes, show that antibiotics bind to different degrees depending on the type of mammalian cell.
PMNs alone caused a reduction in KCPM compared with either L1210 cells or thymocytes (neither of which affected [3H]thymidine uptake by S. aureus). The largest reduction was obtained in the experiment shown in Fig. 2 (105 versus 180 KCPM) ; the smallest can be seen in Fig. 6 (100 versus 135 KCPM). Thus, this reduction accounted for the discrepancy, for instance, between clindamycin incubated with PMNs versus L1210 cells (Fig. 2) , and indicates that the discrepancy was due to intrinsic differences between PMNs and L1210 cells in killing S. aureus. The lower KCPM seen with clindamycin and PMNs represents an additive effect therefore, whereas the reduced KCPM seen with clindamycin and L1210 cells represents the singular contribution of clindamycin. Similar logic applies to the other antibiotics to explain why lower KCPM were obtained when antibiotics were incubated with PMNs.
A comparison of this antibiotic-to-leukocyte binding system with other types of antibiotic binding systems was made previously27): The use of radiolabeled antibiotics is limited by the small number of radiolabeled antibiotics that are available; measuring antibiotic killing of intraleukocyte microbes is above, one disadvantage was that the antibiotic had to bind tightly enough to remain attached to leukocytes through two centrifugation washings. This problem has now been circumvented by centrifuging the antibiotic/leukocyte complex through silicon oil28) which leaves the extracellular antibiotic in the aqueous phase. This was an important modification because some antibiotics, e.g., clindamycin, rapidly exit PMNs in the absence of extracellular antibiotic5).
In the previous study, little difference was observed between PMNS and mononuclear leukocytes in binding clindamycin, fusidic acid, novobiocin, and rifampin; that is, these antibiotics bound about the same to PMNs, and a mixture of blood monocytes and lymphocytes (Table 5, ref 27 ). In the current study, the following antibiotics bound about the same to PMNs and mouse leukemia L1210 cells; clindamycin, fusidic acid, novobiocin, rifampin, and doxycycline.
(A statement of exact equalness is not possible because PMNs alone had the ability to inhibit [3H]thymidine uptake by staphylococci while L1210 cells had no effect.)
Tetracycline was the only apparent exception; it bound less to L1210 cells compared with PMNs.
All antibiotics bound much less to mouse thymocytes. Taken together, these and previous data suggest that the binding of the antibiotics studied is approximately the same to phagocytic cells (human PMNs), non-phagocytic cells (mouse leukemia L1210 cells), and a mixture of both (human mononuclear leukocytes), but much less to thymocytes and essentially none to human erythrocytes.
The composite results show that antibiotics do not bind to all cell types indiscriminately; antibiotics Clindamycin was incubated with PMNS followed by removal of extracellular antibiotic using centrifugation through silicone oil at the concentrations shown (0). Clindamycin was also added directly to wells in microculture trays containing S. aweus and PMNs at O 'C at the concentrations shown (o). The rest of the binding system was used as described earlier. 
